| Composition | Clopidogrel 75mg Aspirin 150mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
CLOPICON AP 75/150 Capsules
CLOPICON AP 75/150 is a combination medicine that contains Clopidogrel 75 mg and Aspirin 150 mg, both of which are effective antiplatelet agents. This dual therapy is widely prescribed for the prevention of blood clots, stroke, heart attack, and other cardiovascular complications. It works by preventing platelets from sticking together, thereby maintaining smooth blood flow and reducing the risk of clot-related blockages in blood vessels.
Doctors often recommend CLOPICON AP 75/150 for patients with a history of acute coronary syndrome, ischemic stroke, peripheral arterial disease, or post-angioplasty and stent placement. By combining the benefits of Clopidogrel and Aspirin, this medicine provides stronger protection against life-threatening clot formation compared to single-drug therapy.
The capsule should be taken strictly under medical supervision, usually once daily, with or without food. It is important to follow the dosage instructions carefully and not to stop the medicine suddenly without consulting a physician.
Some patients may experience mild side effects such as stomach upset, acidity, bruising, or minor bleeding. Long-term use requires regular monitoring to avoid complications. When used correctly, CLOPICON AP 75/150 is an effective therapy for maintaining heart and vascular health.
